May 6, 2020 / 5:16 AM / 23 days ago

BRIEF-Fresenius Says Impact Of Covid-19 On Outlook Cannot Be Assessed

May 6 (Reuters) - Fresenius:

* IMPACT OF COVID-19 ON OUTLOOK CANNOT BE RELIABLY ASSESSED AT THIS TIME

* GROUP MAINTAINS ORIGINAL GUIDANCE, EXCLUDING COVID-19 EFFECTS

* WILL REVISIT GUIDANCE WHEN COMMUNICATING Q2 RESULTS

* KABI WITH EXPECTED DIP IN CHINA PARTIALLY OFFSET BY SPIKE IN DEMAND FOR DRUGS, DEVICES FOR COVID-19 PATIENTS IN EUROPE, U.S.

* HELIOS GERMANY SUPPORTED BY LAW TO EASE FINANCIAL BURDEN ON HOSPITALS

* HELIOS SPAIN’S SIGNIFICANT CONTRIBUTION TO COMBAT COVID-19 FACES REIMBURSEMENT UNCERTAINTIES

* Q1 EBIT OF 1.125 BILLION EUR

* Q1 NET INCOME OF 465 MILLION EUR Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below